Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zachary Jaffa"'
Publikováno v:
World Neurosurgery. 155:160-170
Background Intraparenchymal hemorrhage (IPH), possibly due to reperfusion, after evacuation of a cranial chronic subdural hematoma (cSDH) is a known phenomenon. However, it is sparingly reported and not well understood. Methods An illustrative case s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3485558ccef88676ee6a86691d58b6dd
https://doi.org/10.1016/j.wneu.2021.08.077
https://doi.org/10.1016/j.wneu.2021.08.077
Autor:
Yogesh N Gandhi, Zachary Jaffa, Julian E. Bailes, Raed Abusuwwa, Donald Schleicher, Dean Karahalios, Faran Bokhari, Mohammad Arshad, Vimal Patel, Jeanne F Barkley, Nicholas Hempeck, Shakeel A. Chowdhry, Barry Sears
Publikováno v:
Journal of Neurosurgery. 133:598-602
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465835550115a03f0c22d939514ecf20
https://doi.org/10.3171/2020.3.jns20183
https://doi.org/10.3171/2020.3.jns20183
I mmunohistochemical Characterization of Microglia in a De‐identified Human Meningioma Brain Culture
Autor:
Alejandro M. S. Mayer, Sasha Singh, Robin Schneider, Diane Sierens, Laura E. Phelps, Tina Moazezi, Matthew Erbst, Zylfi Memedovski, Zachary Jaffa, Donald Schleicher
Publikováno v:
The FASEB Journal. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3ac5bab8e10613c71a5684dbfd48b89
https://doi.org/10.1096/fasebj.2021.35.s1.00138
https://doi.org/10.1096/fasebj.2021.35.s1.00138
Autor:
Sihai Dave Zhao, John I. Clark, Anne O'Neill, Robert I. Haddad, Zachary Jaffa, Sewanti Limaye, Sarah Riley, Douglas Adkins, Marshall R. Posner
Publikováno v:
Oral Oncology. 49:835-841
Summary Objectives There are limited chemotherapeutic options for advanced recurrent or metastatic SCCHN. The efficacy and toxicity of docetaxel with or without vandetanib was investigated in these patients. Materials and Methods Patients with pathol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::974bb69919c80447cf34668f1e2a94fe
https://doi.org/10.1016/j.oraloncology.2013.04.010
https://doi.org/10.1016/j.oraloncology.2013.04.010
Autor:
Roger B. Davis, Eric A. Macklin, Nicholas J Dreyer, Roy B. Tishler, Weidong Lu, Hailun Li, Zachary Jaffa, David S. Rosenthal, Robert I. Haddad, Jochen H. Lorch, Laura A. Goguen, Marshall R. Posner, Tyler C Haddad, Peter M. Wayne, Elaine Burke, Julie E. Buring
Publikováno v:
Journal of Clinical Oncology. 31:6058-6058
6058 Background: Dysphagia is a common side effect following chemoradiation (CRT) in pts with head and neck cancer (HNC). The purpose of this pilot trial was to assess the feasibility of recruiting HNC pts and to collect preliminary data on the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a4716ffac5d8ca9736954ea9efeb6be
https://doi.org/10.1200/jco.2013.31.15_suppl.6058
https://doi.org/10.1200/jco.2013.31.15_suppl.6058
Autor:
Vijaya Thotakura, Jochen H. Lorch, Zachary Jaffa, Robert I. Haddad, Roy B. Tishler, Sewanti Limaye, David J. Sher, Wei Dai, Glenn J. Hanna, Vidya Nair, Guilherme Rabinowits, Marshall R. Posner
Publikováno v:
Journal of Clinical Oncology. 30:5582-5582
5582 Background: HPV status is a major prognostic marker for survival in patients with OPC. We examined overall survival (OS) and progression free survival (PFS) in patients with OPC and known HPV status treated at Dana-Farber Cancer Institute with S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bd0e437d313ae17a53cad412fcef4fb
https://doi.org/10.1200/jco.2012.30.15_suppl.5582
https://doi.org/10.1200/jco.2012.30.15_suppl.5582
Autor:
Douglas Adkins, Zachary Jaffa, Nicholas J. Sarlis, Robert I. Haddad, Marshall R. Posner, Lori J. Wirth, Roy B. Tishler, Fadlo R. Khuri, Jochen H. Lorch, Jeffrey W. Clark
Publikováno v:
Journal of Clinical Oncology. 28:5563-5563
5563 Background: PARADIGM is a multicenter phase III study comparing TPF (docetaxel, cisplatin, and 5-fluorouracil)-based ST (Arm A) to upfront cisplatin CRT (Arm B) in patients (pts) with LAHNC. P...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1c5239011b330d6e957f2c23d09c58d
https://doi.org/10.1200/jco.2010.28.15_suppl.5563
https://doi.org/10.1200/jco.2010.28.15_suppl.5563